Mumbai 400072, India
+91-90045 60540
info@omnisciencecapital.com

Category: OmniView

Science of Alpha from Safety

It is time for action

It is Time for Action

It is Time for Action When the valuations are favorable, the Scientific Investor starts investing Let us begin with the clarification that this is not—and cannot be—investment advice which depends on each individual’s specific circumstances, objectives and risk profile. The question on many people’s minds today is should they invest or exit? We are giving…
Read more

OmniScience Strategies India Annual Update for 2021

OmniScience Strategies India Annual Update for 2021 A Quiver full of Multi-Thematic Investment Opportunities Enhance Safety, Enhance Growth, Enhance Returns Mr. Market delivered fantastic returns, with Asian exception 2021 has been a fantastic year for equity investors across many markets across the World. Sensex has delivered 23.23%, Nifty 25.59%, S&P 500 28.71%, Nasdaq-100 27.51% and…
Read more

Omni Supreme & Omni AIoT: Providing Exposure To Multiple Growth Vectors

OmniScience runs two US strategies, viz., Omni Supreme and Omni AIoT. Both strategies are based on the Scientific Investing Framework which focuses on selecting from the investment universe by eliminating Capital Destroyers, Capital Eroders, and Capital Imploders; and, creating a SuperNormal Portfolio of SuperNormal Companies at SuperNormal Prices from the Capital Multipliers which remain. This…
Read more

Are US equities in sweet spot?

Are US Equities In A Sweet Spot?

Are US Equities in a sweet spot: Does an appreciated INR makes it sweeter for Indian Investors? US markets present several well-known companies with popular products across multiple sectors One can start with a 5% to 10% allocation to US markets and take it up to 20-30% depending on the suitability to their investment goals…
Read more

Dividends Are Divine In A ZIRP World

Generating Higher Income with Investment Grade Equity – AAA rated companies Summary In tandem with the ZIRP-world RBI has kept interest rates low resulting in fixed income instruments such as bank FDs, GSecs, Corporate bonds, Debt funds, etc. yielding low returns leaving income-dependent investors searching for yields. Contrary to the typical investor chasing yields in…
Read more

Omni Supreme US: Scientific Investing in the Land of Opportunity

Omni Supreme US: Scientific Investing in the Land of Opportunity US Supreme segments provide exposure to four different growth themes Omni Supreme US is the multi-cap investment offering where the portfolio is selected from the top 1500 large, mid and small cap stocks There are four key investments themes that the multi-cap portfolio gives exposure…
Read more

Is the Economy on a Great Rebound?

Is the Economy on a Great Rebound? The ‘Great Rebound’ of the Economy offers a Great Investment Opportunity Economic data points indicate that economic activity has already rebounded and reached levels seen pre-Covid-19 This ‘Great Rebound’ is supported by the fact that the outlook for the next several quarters and for the next 2 years…
Read more

From the Mythical Bubble into a Vacuum

From the Mythical Bubble into a Vacuum Bu(r)sting the myth of the current stock market bubble Claiming that the equity market is in a bubble sounds sophisticated and conservative. However, is there any truth to it? And, if true, is it an actionable statement? There are more than 10 important questions that a Scientific Investor…
Read more

Entering the Matrix-Understanding the Intelligent Digital Universe of the Omni AIoT US Portfolio

Global OmniView August 2020 Entering the Matrix-Understanding the Intelligent Digital Universe of the Omni AIoT US Portfolio Download the full PDF report: Entering the Matrix – Understanding Omni AIoT US Segments   Artificial Intelligence (AI) is a multi-trillion-dollar opportunity and the Omni AIoT US portfolio is one of its kind investment opportunity that provides exposure…
Read more

Mr. Market Plays Catch-up While Scientific Investing Generates Alpha

Global OmniView July 2020 Mr. Market plays catch-up while Scientific Investing generates alpha Scientific Investing portfolios exhibiting broad-based outperformance All segments of the Omni Supreme US Multicap strategy have outperformed benchmark. All segments continue to be fundamentally strong with attractive valuations Omni Supreme US Multicap and AIoT are inevitables that investors must consider adding to…
Read more